Please note: This archive was last updated in 2005.

About PATH

PATH is an international, nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public- and private-sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act. PATH improves global health and well-being.

PATH currently works in more than 100 countries in the areas of reproductive health; vaccines and immunization; HIV, AIDS, and tuberculosis; and children’s health and nutrition. Staff provide expertise in public health, epidemiology, technology design, technology development and transfer, technology introduction, immunodiagnostics and vaccine development, vaccine-distribution systems, business development, education and training, communication, advocacy, and procurement.

In recognition of its expertise in specific areas, PATH has been designated by the World Health Organization (WHO) as a Collaborating Center in three technical areas: Research in Human Reproduction, Vaccinology, and AIDS. As a Collaborating Center, PATH provides technical assistance to WHO and to ministries of health.

Headquartered in Seattle, Washington, since its inception in 1978, PATH operates 19 offices in 13 countries. PATH’s 2004 budget is $96 million, which is provided by foundations, the U.S. government, other governments, multilateral agencies, corporations, and individuals. PATH’s nine-member board of directors consists of representatives from countries where PATH works, including the United States. PATH is registered as a 501(c)3 tax-exempt organization.

For more information, please visit

Top of page


In addition to maintaining the RHO website, PATH publishes and distributes Outlook, a quarterly newsletter that features research findings and other news related to reproductive health. Issues of Outlook are available in English at no charge to readers working in or with developing countries. Selected issues are also available in Chinese, French, Hindi, Portuguese, Russian, and Spanish. Recent issues have addressed misoprostol use in obstetrics and gynecology; vasectomy; an update on IUDs, implants, and oral contraceptives; human rights and reproductive health; contraceptive supply security; cervical barrier devices; violence against women; and breast cancer.

Top of page

For More Information

For more information, please visit the PATH website (, or browse online issues of Outlook ( Additional publications and materials are available through PATH's online catalog (

Top of page